IDG Capital, CDH Investments Lead $44M Series B Round In Chinese Biotech Start-Up

Login to View

Creative Biosciences, a Chinese biotechnology start-up focusing on colorectal cancer detection, announced on Friday the completion of a RMB300 million (US$44.64 million) series B round of financing led by Boston-born investment firm IDG Capital and Chinese private equity firm CDH Investments.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access Over 11,000 stories and data posts over the past 8 years!

Register Now

Already have an account or paid subscription? Log in